Today: 21 May 2026
JPMorgan stock slips after record run as investors eye Jan. 13 earnings
6 January 2026
1 min read

JPMorgan stock slips after record run as investors eye Jan. 13 earnings

New York, January 6, 2026, 11:19 EST — Regular session

  • JPMorgan shares edge lower after Monday’s record high as financials rally cools
  • Bank’s new Special Advisory Services unit and rate-cut bets keep focus on fee growth
  • Next catalyst: JPMorgan’s fourth-quarter results on January 13 before the bell

JPMorgan Chase & Co (JPM.N) shares slipped 0.3% to $333 in late morning trade on Tuesday, easing after a sharp rally that pushed the bank to record highs in the prior session.

The move matters because JPMorgan is set to open the U.S. bank earnings season next week, and investors are looking for fresh clues on how 2026 may shape up for loan growth, credit quality and capital returns. Traders will also watch net interest income — the gap between what banks earn on loans and pay on deposits — as markets debate the timing and size of Federal Reserve rate cuts.

On Monday, JPMorgan rose more than 3% and hit a record high alongside Goldman Sachs and Morgan Stanley as investors rotated into financials ahead of quarterly reports, a Reuters market wrap showed. “The mood has been favoring financial stocks in recent days,” said Steve Sosnick, chief market analyst at Interactive Brokers. Reuters

The bank also drew attention this week after J.P. Morgan, its investment bank, launched a Special Advisory Services unit to advise a select group of clients beyond traditional financing and deal work, Reuters reported. The unit will focus on themes including artificial intelligence, cybersecurity, digital assets and geopolitics and will be led by Liz Myers, the bank’s global chair of investment banking.

Broader markets were steady on Tuesday as Wall Street extended its early-year rally, with investors positioning for Friday’s U.S. jobs report that could shape the Fed policy outlook. Fed Chair Jerome Powell has urged caution on further rate reductions until there is more clarity on the labor market, Reuters reported.

JPMorgan said it will release fourth-quarter and full-year 2025 results at about 7:00 a.m. ET on Tuesday, January 13, followed by an 8:30 a.m. conference call. Investors are likely to focus on management’s commentary on trading and investment-banking activity, expense discipline and credit trends.

Dividend watchers also have January 6 circled on the calendar: JPMorgan’s board previously declared a quarterly dividend of $1.50 a share, payable on January 31 to stockholders of record at the close of business on January 6, the company said.

One risk for the stock heading into earnings is cost pressure. In December, consumer and community banking chief Marianne Lake said the firm expects 2026 expenses to climb to about $105 billion, above analysts’ average estimate at the time, and noted fourth-quarter investment-banking revenue was tracking up low-single digits while markets revenue was seen up low-teens.

What comes next for traders is a two-step test: Friday’s nonfarm payrolls report (January 9) for the rate path, then JPMorgan’s results and guidance on January 13, which are expected to set the tone for big-bank earnings season.

Stock Market Today

  • Euronext CEO Dismisses Near-Term Merger with Deutsche Boerse
    May 21, 2026, 10:33 AM EDT. Euronext CEO Stephane Boujnah ruled out a merger with Deutsche Boerse in the near future despite acknowledging that such a deal "would make sense." The CEO's statement on Thursday signals no immediate plans for consolidation between the two major European stock exchanges. The move maintains the status quo in the region's exchange landscape, for now.

Latest articles

Apellis Stock Disappears From Nasdaq as Biogen $41 Billion Buyout Faces Final Hurdle

Apellis Stock Disappears From Nasdaq as Biogen $41 Billion Buyout Faces Final Hurdle

21 May 2026
Biogen completed its $5.3 billion acquisition of Apellis Pharmaceuticals, ending APLS trading on Nasdaq as of May 15. Former Apellis shareholders receive $41 per share in cash and a contingent value right tied to future Syfovre sales. Biogen shares rose 0.6% early Thursday. The CVR pays only if Syfovre meets specific sales milestones; there is no guarantee of payout.
Quantum computing stocks rally: IonQ, Rigetti, D-Wave, QUBT prices jump as traders look to the week ahead

Quantum Computing Stock Surges After $2 Billion U.S. Quantum Bet — Why QUBT Traders Are Watching

21 May 2026
Quantum Computing Inc. shares rose 12.2% to $10.73 in early Nasdaq trading Thursday, with volume near 16 million, after a U.S. government funding push for the sector. QCI was not named among recipients of the $2 billion federal quantum investment reported by Reuters. Other stocks in the sector, including Rigetti and D-Wave, posted larger gains. QCI recently reported first-quarter revenue of $3.7 million after acquiring Luminar Semiconductor.
Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings
Previous Story

Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure
Next Story

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Go toTop